AAVantgarde Bio, Corp USA BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

NCT07737964 clinical trial report covering Acetazolamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262937 clinical trial report covering Bempedoic acid/Ezetimibe, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07739368 clinical trial report covering Ferric Maltol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262896 clinical trial report covering ZOC2019619, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262894 clinical trial report covering ZOC2019619, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738198 clinical trial report covering Stannous protoporphyrin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07739654 clinical trial report covering Cisplatin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07739914 clinical trial report covering Everolimus, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738172 clinical trial report covering Osimertinib mesylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07740421 clinical trial report covering NH-002(Trust Bio-sonics), Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07738276 clinical trial report covering Tirzepatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.